Accelerate Diagnostics (AXDX) Misses Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts AXDX Hot Sheet
Join SI Premium – FREE
Accelerate Diagnostics (NASDAQ: AXDX) reported Q2 EPS of ($0.37), $0.05 worse than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Movano (MOVE) Misses Q2 EPS by 195c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
